Added to YB: 2025-05-15
Pitch date: 2025-05-12
BVXP.L [neutral]
Bioventix PLC
-38.1%
current return
Author Info
Increasing Odds shares their investment journey in their newsletter. Sign up for the newsletter.
Company Info
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
Market Cap
GBP 148.9M
Pitch Price
GBP 27.46
Price Target
N/A
Dividend
5.44%
EV/EBITDA
13.57
P/E
19.24
EV/Sales
10.52
Sector
Biotechnology
Category
N/A
Exploring AIM: A-Z Part 4 - Bioventix PLC
BVXP.L pass: £145M biotech with 75% PBT margins focused on antibodies for diagnostics and Alzheimer's biomarkers. Revenue +1% to £6.73M, PBT -4% to £5.05M from R&D spend. Expects flat H1 25, growth in 2026. 25x fwd P/E rich valuation with CEO owning 5.7%. Pass due to technical complexity.
Read full article (1 min)